Find clinical trials for Sanofi. Search for Sanofi clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 62
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Baltimore MD, Miami FL, DuBois PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07053423
Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Providence RI, Maspeth NY, New York NY, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184944
Phase 3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Providence RI, Worcester MA, New Haven CT, Maspeth NY,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184996
Phase 3, Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Providence RI, Worcester MA, Maspeth NY, New York NY,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07185009
Phase 3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Boston MA, Providence RI, Worcester MA, New Haven CT,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184931
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
for
Hemophilia A
Location: Flowood MS, Los Angeles CA
Sponsor: Sanofi
Sex: Male
Age: 12+
Code: NCT06145373
Recruiting
Phase 1b/2 Study of IV Sarilumab in Adult With RA
for
Rheumatoid Arthritis
Location: Duncansville PA, Hollywood FL, Hialeah FL,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07704580
Phase 1, Phase 2, Recruiting
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
for
Graves' Disease
Location: Sherbrooke, Calgary, Surrey
Sponsor: Sanofi
Sex: All
Age: 18 - 70+
Code: NCT06984627
Phase 2, Recruiting
Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
for
Pneumococcal Immunization, Healthy Volunteers
Location: Houston TX
Sponsor: Sanofi
Sex: All
Age: 0
Code: NCT06975878
Phase 3, Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Halifax, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase 3, Recruiting
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
for
Crohn's Disease
Location: Boston MA, Harrisburg PA, Richmond VA, Lighthouse PT FL,
Sponsor: Sanofi
Sex: All
Age: 18 - 70+
Code: NCT06958536
Phase 2, Recruiting
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
for
Plasma Cell Myeloma Refractory
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06356571
Phase 2, Recruiting
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
for
Sickle Cell Disease
Location: The Bronx NY, Staten Island NY, Baltimore MD,
Sponsor: Sanofi
Sex: All
Age: 10 - 65
Code: NCT06975865
Phase 3, Recruiting
Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy
for
Chronic Graft Versus Host Disease
Location: Valhalla NY, Baltimore MD, Miami FL
Sponsor: Kadmon, a Sanofi Company
Sex: All
Age: 12+
Code: NCT05567406
Phase 2, Recruiting
Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)
for
Meningococcal Infection
Location: Swiftwater PA
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All
Age: 0+
Code: NCT04843111
Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne
for
Acne
Location: Jacksonville FL, Brandon FL, New Orleans LA, Encino CA
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All
Age: 18 - 45
Code: NCT07013747
Phase 1, Phase 2, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne